BillionToOne Insider Sold Shares for Personal Liquidity
John Roderick Ten Bosch sold over 1,400 shares of the Menlo Park-based company in September.
Updated on Sept. 21, 2026 in Public Companies
Live Poll
Should stock sales by company insiders concern you as an investor?
Insider John Roderick Ten Bosch completed a sale of 1,416 shares of BillionToOne Class A Common Stock. The transaction was conducted as part of a pre-established liquidity plan.
Why it matters
The sale serves as a routine financial management event for the insider. The transaction occurred under a Rule 10b5-1 trading plan adopted earlier this summer.
BillionToOne, which employs 713 people and holds a $4.6 billion market cap, recently reported $397 million in TTM revenue. The insider trade involved 1,416 shares at an average price of $97.54.
The players
John Roderick Ten Bosch
He is an insider at BillionToOne who managed personal assets through a scheduled stock sale.
BillionToOne
This Menlo Park-headquartered company specializes in molecular diagnostics and reports significant year-over-year revenue growth.
The details
The shares were sold on September 9, 2026, pursuant to a Rule 10b5-1 trading plan that the insider established on June 2, 2026. Following this sale, Ten Bosch retains 25,051 shares valued at approximately $2.4 million.
Timeline
June 2, 2026: The Rule 10b5-1 trading plan was formally adopted.
September 9, 2026: The insider sold 1,416 shares of stock.
Market Landscape
The use of Rule 10b5-1 plans reflects a growing trend among corporate executives to automate liquidity events, insulating them from potential market volatility. This shift helps the company maintain stability by removing subjective timing decisions from the hands of individual insiders.
Routine insider sales generally do not signal immediate changes to company operations or retail pricing for customers. Shareholders may monitor these filings to gauge long-term confidence in the company's financial trajectory.
The takeaway
Scheduled selling plans allow insiders to manage personal wealth without triggering market speculation regarding internal company performance. Investors should look at total insider ownership and long-term revenue growth when evaluating the health of high-growth firms.
Further reading
Learn more about corporate financial filings in the Public Companies section.
Live Poll
Should stock sales by company insiders concern you as an investor?
